Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Ordinary Shares, nominal value Euro 0.04 per share
-
Shares outstanding
-
105,371,575
-
Total 13F shares
-
41,291,570
-
Share change
-
-3,135,751
-
Total reported value
-
$54,918,956
-
Put/Call ratio
-
18%
-
Price per share
-
$1.33
-
Number of holders
-
63
-
Value change
-
-$5,787,634
-
Number of buys
-
24
-
Number of sells
-
37
Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) as of Q1 2025
As of 31 Mar 2025,
ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,291,570 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., Privium Fund Management B.V., Affinity Asset Advisors, LLC, MILLENNIUM MANAGEMENT LLC, Sio Capital Management, LLC, Aberdeen Group plc, UBS Group AG, Kynam Capital Management, LP, DAFNA Capital Management LLC, and Siren, L.L.C..
This page lists
63
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.